Search Tag: Chief Financial Officer

Cardiology Management

Opsens-appoints-john-hannigan-as-chief-financial-officer

2023 27 Mar

OpSens Inc. , a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced the appointment of John Hannigan as Chief Financial Officer, effective immediately.   Mr. Hannigan is a highly experienced financial executive with more than 22 years of proven financial expertise...Read more

Cardiology Management

Cardurion-pharmaceuticals-appointments-elizabeth-radcliffe-as-chief-financial-officer

2023 19 Jan

Cardurion Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases announced the appointment of Elizabeth Radcliffe as Chief Financial Officer. A seasoned strategic finance leader, Ms. Radcliffe brings to Cardurion more...Read more

Cardiology Management

Cardior-appoints-axel-sven-malkomes-as-chief-financial-officer

2022 03 Nov

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Axel-Sven Malkomes as Chief Financial Officer (CFO). Mr. Malkomes joins the executive leadership team to lead Cardior’s financial operations and planning, risk and compliance,...Read more

Cardiology Management

Confluent-medical-technologies-names-matthew-k-eckl-as-chief-financial-officer

2022 17 Oct

Confluent Medical Technologies, Inc. announced that Matthew K. Eckl, has been appointed as Chief Financial Officer (“CFO”) for the company, effective October 17, 2022. “We are thrilled to welcome Matt to Confluent,” said Dean Schauer, Confluent’s Chief Executive Officer. “Matt has exceptional experience in finance and financial operations as well...Read more

Cardiology Management

Ancora-heart-appoints-david-j-tucker-as-chief-financial-officer

2022 12 Oct

Senior Financial Leader is Company’s Second C-Level Hire in 2022 Ancora Heart, Inc.,  a company developing a novel device-based therapy to address heart failure (HF) announced that David J. Tucker has joined the company as chief financial officer. He will direct the company’s financial strategies and operations as it continues to enroll patients...Read more